Condition: Patient Satisfaction
Intervention: Drug: Budesonide, Formoterol Fumarate Dihydrate
Sponsor: Teva Pharma GmbH
Active, not recruiting – verified March 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Patient Satisfaction
Intervention: Drug: Budesonide, Formoterol Fumarate Dihydrate
Sponsor: Teva Pharma GmbH
Active, not recruiting – verified March 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Dermatitis, Atopic; Asthma; Healthy
Intervention: Other: Allergic Skin Reaction (ASR) Testing and Skin Blister Induction
Sponsor: Janssen Research & Development, LLC
Not yet recruiting – verified January 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Biological: Benralizumab; Biological: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
International Business Times AU |
Experts Evaluate Use of Allergy And Asthma Devices
International Business Times AU Inhalers and adrenalin auto-injectors are usually prescribed to patients with asthma and severe allergies, but instructions on how to use these devices are not often taught, according to various research groups. Incorrect use of these medical devices … Wrong-way drunk driver covers 50 km |
View full post on asthma – Google News
Condition: Oral Corticosteroid Dependent Asthma
Interventions: Biological: Tralokinumab; Other: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified October 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
St. Louis Public Radio |
NIH Seeks African Americans To Evaluate Asthma Medications
St. Louis Public Radio "They like the fact that we're always available to help answer questions, all of the asthma medications are provided free of charge, we will help folks with travel, with parking ? with any of the logistics of helping them attend study visits, to … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: NEUMOTEROL 400 (BFF 400/12 mcg) single capsule inhaler; Drug: SYMBICORT forte (BFF 320/9mcg) TURBUHALER inhaler; Drug: NEUMOTEX 400 (Budesonide 400 mcg); Drug: Salbutamol 100 mcg pMDI
Sponsors: GlaxoSmithKline; Laboratorios Phoenix
Not yet recruiting – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: budesonide/formoterol ‘as needed’ + budesonide placebo bid; Drug: budesonode bid + terbutaline ‘as needed’
Sponsor: AstraZeneca
Not yet recruiting – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Uncontrolled Asthma
Interventions: Biological: Tralokinumab; Biological: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Beclometasone Dipropionate 100 µg + Formoterol Fumarate 6 µg; Drug: Beclometasone Dipropionate 200 µg + Formoterol Fumarate 6 µg; Drug: Placebo
Sponsor: Chiesi Farmaceutici S.p.A.
Recruiting – verified May 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days